Citation Impact
Citing Papers
Cancer Chemopreventive and Therapeutic Effects of Diosgenin, a Food Saponin
2009
The lipid composition and biochemistry of freshwater fish
1987 Standout
The biological action of saponins in animal systems: a review
2002 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Acute phase proteins in dogs and cats: current knowledge and future perspectives
2005 Standout
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
2003
Saponins as cytotoxic agents: a review
2010 Standout
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
New approaches for treatment in diabetes: Aldose reductase inhibitors
1995
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
1992 StandoutNature
Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor
1997
Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation
2003 Standout
Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis
2003
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid
2003
Design, synthesis of methotrexate-diosgenin conjugates and biological evaluation of their effect on methotrexate transport-resistant cells
2016
Vitamin E Intake and Risk of Cataracts in Humansa
1989
Diabetes, oxidative stress, and antioxidants: A review
2003 Standout
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Fish bioaccumulation and biomarkers in environmental risk assessment: a review
2002 Standout
Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells
2003
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
The role of aldose reductase in the development of diabetic complications
1988
Gemfibrozil
1988
Ultrahigh resolution drug design I: Details of interactions in human aldose reductase–inhibitor complex at 0.66 Å
2004 Standout
Anorexigenic and Orexigenic Hormone Modulation of Mammalian Target of Rapamycin Complex 1 Activity and the Regulation of Hypothalamic Agouti-Related Protein mRNA Expression
2012 Standout
G protein-coupled receptors for energy metabolites as new therapeutic targets
2012
The role of polyols in the pathophysiology of hypergalactosemia
1995
Effect of long-term treatment with $beta;-blocker on cardiac hypertrophy in SHR
1989
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Carcinogenicity categorization of chemicals—new aspects to be considered in a European perspective
2004 Standout
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Effects of NaCl, glucose, and aldose reductase inhibitors on cloning efficiency of renal medullary cells
1990
Chemical analysis of the lung alveolar surfactant obtained by alveolar micropuncture
1973
Robbins and Cotran Pathologic Basis of Disease
2020 Standout
Heavy metal induced oxidative stress & its possible reversal by chelation therapy.
2008 Standout
Primary Pulmonary Responses to Toxic Agents
1977
Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans
1983
Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications.
1992
Paraquat: model for oxidant-initiated toxicity.
1984 Standout
Oxygen Radicals and Human Disease
1987 Standout
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses
2005 Standout
Therapeutic applications of fenugreek.
2003 Standout
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
1999 Standout
Occurrence of drugs in German sewage treatment plants and rivers
1998 Standout
8 The Medicinal Chemistry of Aldose Reductase Inhibitors
1987
Implication of steroid saponins and sapogenins in the hypocholesterolemic effect of fenugreek
1991
CARDIOVASCULAR EFFECTS OF ?-ADRENORECEPTOR BLOCKING AGENTS AFTER INTRACEREBROVENTRICULAR ADMINISTRATION IN CONSCIOUS NORMOTENSIVE CATS
1974
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
1986 Standout
Computer Simulation Studies of the Catalytic Mechanism of Human Aldose Reductase
2000 StandoutNobel
Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet.
1982
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
1999 Standout
Metabolism of diosgenin-derived saponins: implications for hepatogenous photosensitization diseases in ruminants
2001
Chlorinated Methanes and Liver Injury: Highlights of the Past 50 Years
2000
REDUCED ADRENAL AMINE SYNTHESIS IN SPONTANEOUSLY HYPERTENSIVE RATS AFTER LONG‐TERM TREATMENT WITH PROPRANOLOL
1977 StandoutNobel
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of E. Greselin being referenced
Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.
1985
Influence of acetone on the severity of the liver injury induced by haloalkane mixtures
1991
Species differences in the nephrotoxic response to S-(1,2-dichlorovinyl)glutathione
1992
Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites
1990
Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.
1977
The Metabolic Disposition of Etodolac in Rats, Dogs, and Man
1981
Lung phospholipids: Biochemical and histologic changes induced by the cholesterol biosynthesis inhibitor AY-9944
1967
Evaluation of the lipid-lowering activity of AY-25,712 in rats
1982
Studies on the disposition of diosgenin in rats, dogs, monkeys and man
1979
Prevention of Cataract Development in Severely Galactosemic Rats by the Aldose Reductase Inhibitor, Tolrestat
1985
Chronic Propranolol Treatment in Young Spontaneously Hypertensive and Normotensive Rats
1973
An inhibitor of cholesterol biosynthesis and the alveolar macrophages.
1966
The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats
1985
Effect of AY-25,712 and Other Lipid-Lowering Agents on Liver Catalase and Liver Carnitine Acetyltransferase in Rats
1983